https://commons.ufh.ac.za/vital/access/manager/Index ${session.getAttribute("locale")} 5 Infrared evidence for the transmission of electronic effects through a metal atom in a series of new cadmium complexes https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6371 Tue 14 May 2024 12:52:57 SAST ]]> Complexes of zinc, cadmium and mercury with primary aromatic amines https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6369 Tue 14 May 2024 12:52:31 SAST ]]> Complexes of mercury(II) and zinc(II) with primary aromatic amines https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6370 Tue 14 May 2024 12:52:07 SAST ]]> Ligand substitution effects in uranyl ο-hydroxyarylcarbonyl complexes https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6372 Tue 14 May 2024 12:51:46 SAST ]]> The structure of aliphatic amine adducts of uranyl acetylacetonate. I. Dioxobis(2,4-pentanedionato)mono (2-N-methylaminopentan-4-one)uranium(VI) https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6373 Tue 14 May 2024 12:51:25 SAST ]]> The crystal and molecular structure of the bis(4-N, N1-dimethylaminopyridine) solvate of disalicylicacidatobis(nitrotodioxouranium)(VI) https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6415 Tue 14 May 2024 12:51:03 SAST ]]> The structure of aliphatic amine adducts of uranyl acetylacetonate. IV. Dioxobis(2,4-pentanedionato) mono(2-aminopentan-4-one)uranium(VI) https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6420 Tue 14 May 2024 12:50:38 SAST ]]> The structure of aliphatic amine adducts of uranyl acetylacetonate. III. Dioxobis(2,4-pentanedionato)mono (2-N-isopropylaminopentan-4-one)uranium(VI) https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6419 Tue 14 May 2024 12:50:17 SAST ]]> The structure of aliphatic amine adducts of uranyl acetylacetonate. II. Dioxobis(2,4-pentanedionato)mono (2-N,N-dimethylaminopentan-4-one)uranium(VI) https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6416 Tue 14 May 2024 12:49:56 SAST ]]> Bioavailability and activity of 0.1% amcinonide preparations: comparison with proprietary topical corticosteroid formulations of differing potencies https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6447 Tue 14 May 2024 12:49:19 SAST ]]> Résultats des études menées en Angleterre: détermination de la posologie optimale https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6449 Tue 14 May 2024 12:48:46 SAST ]]> Possible dosage regimens for topical steroids assessed by vasoconstrictor assays using multiple applications https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6450 Tue 14 May 2024 12:47:47 SAST ]]> Dilution of topical corticosteroid formulations https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6377 Tue 14 May 2024 12:46:22 SAST ]]> The human skin-blanching assay as an indicator of topical corticosteroid bioavailability and potency: an update https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6440 Tue 14 May 2024 12:45:56 SAST ]]> In vitro systems for the assessment of drug release from topical formulations and trans-membrane permeation https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6441 Tue 14 May 2024 12:45:31 SAST ]]> In vitro diffusion cell design and validation. I. A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phase https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6431 Tue 14 May 2024 12:45:06 SAST ]]> Blanching activities of betamethasone 17-valerate formulations: effect of the dosage form on topical drug availability https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6432 Tue 14 May 2024 12:44:46 SAST ]]> Topical corticosteroid-induced skin blanching measurement, eye or instrument? https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6378 Tue 14 May 2024 12:44:27 SAST ]]> The human skin-blanching assay for comparing topical corticosteroid availability https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6433 Tue 14 May 2024 12:44:05 SAST ]]> Sensitivity of different areas of the flexor aspect of the human forearm to corticosteroid-induced skin blanching https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6394 Tue 14 May 2024 12:43:42 SAST ]]> In vitro diffusion cell design and validation. II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6422 Tue 14 May 2024 12:42:56 SAST ]]> Accuracy and reproducibility of the multiple-reading skin blanching assay https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6439 Tue 14 May 2024 12:42:35 SAST ]]> Ranking of topical corticosteroids: principles and results https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6434 Tue 14 May 2024 12:42:12 SAST ]]> The selection and use of natural and synthetic membranes for in vitro diffusion experiments https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6379 Tue 14 May 2024 12:41:53 SAST ]]> In vitro release of propranolol hydrochloride from topical vehicles https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6435 Tue 14 May 2024 12:41:31 SAST ]]> The effects of elevated and ambient temperature conditions on dilutions of fluocinolone acetonide ointment assessed using the human skin-blanching assay https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6380 Tue 14 May 2024 12:41:05 SAST ]]> In vivo/in vitro assessments of topical hydrocortisone availability: correlation between blanching assay and laboratory cell experiments https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6438 Tue 14 May 2024 12:40:50 SAST ]]> Assessing penetration enhances for topical corticosteroids https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6442 Tue 14 May 2024 12:40:28 SAST ]]> The human skin-blanching assay for in vitro topical corticosteroid assessment. I. Reproducibility of the assay https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6381 Tue 14 May 2024 12:39:53 SAST ]]> The use of supersaturated solutions for the percutaneous delivery of rooperol tetra-acetate https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6340 Tue 14 May 2024 12:39:15 SAST ]]> The requirements for accurate analysis of pharmaceutical research at South African Universities https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6367 Tue 14 May 2024 12:38:47 SAST ]]> Precision of tristimulus chromameter results from corticosteroid-induced skin blanching https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6342 Tue 14 May 2024 12:38:21 SAST ]]> New developments in the methodology available for the assessment of topical corticosteroid-induced skin blanching https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6384 Tue 14 May 2024 12:37:59 SAST ]]> In vitro permeation of progesterone from a gel through the shed skin of three different snake species https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6366 cobra>viper. These differences may be due to the thickness of the skin and the hinge:scale ratio. The results indicate that shed snake skin is not a model membrane for human skin.]]> Tue 14 May 2024 12:37:35 SAST ]]> Can shed snakeskin be considered to be a model membrane for human stratum corneum? https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6383 Tue 14 May 2024 12:37:01 SAST ]]> Comparison of visual CR-200 and CR-300 chromameter data obtained from the corticosteroid-induced skin-blanching assay https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6344 Tue 14 May 2024 12:35:42 SAST ]]> Chromametry: measuring precision of diurnal and local variation of human forearm skin colour https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6343 Tue 14 May 2024 12:35:18 SAST ]]> Bioequivalence testing of topical dermatological formulations, the gap between science and legislation https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6341 Tue 14 May 2024 12:34:31 SAST ]]> Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6425 Tue 14 May 2024 12:33:53 SAST ]]> Analysis of chromameter results obtained from corticosteroid-induced skin blanching assay: comparison of visual and chromameter data https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6426 Tue 14 May 2024 12:33:28 SAST ]]> The registration of generic topical corticosteroid formulations in South Africa: a report https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6368 Tue 14 May 2024 12:32:59 SAST ]]> Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital image analysis https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6427 Tue 14 May 2024 12:32:38 SAST ]]> Foam drug delivery in dermatology: beyond the scalp https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6418 Tue 14 May 2024 12:32:15 SAST ]]> Analysis of chromameter results obtained from corticosteroid-induced skin blanching. I. Manipulation of data https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6424 Tue 14 May 2024 12:12:30 SAST ]]> Application of the Minolta chromameter to the assessment of corticosteroid-induced skin blanching https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6451 Tue 14 May 2024 12:10:50 SAST ]]> Comparative blanching activities of proprietary diflucortolone valerate topical preparations https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6350 Tue 14 May 2024 10:53:07 SAST ]]> Assessment of some variables affecting the blanching activity of betamethasone 17-valerate cream https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6396 Tue 14 May 2024 10:52:37 SAST ]]> The release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6397 Tue 14 May 2024 10:51:53 SAST ]]> Comparative bioavailability of some locally manufactured betamethasone valerate containing preparations https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6399 Tue 14 May 2024 10:50:36 SAST ]]> Assessment of topical corticosteroid preparations: the human skin-blanching assay https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6374 Tue 14 May 2024 10:50:13 SAST ]]> Relative potencies of topical corticosteroid formulations https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6375 Tue 14 May 2024 10:49:55 SAST ]]> Determination of erythromycin in serum and urine by high performance liquid chromatography with ultraviolet detection https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6428 Tue 14 May 2024 10:49:36 SAST ]]> Reply to correspondence: P.M. Gaylarde (1986) The human skin blanching assay—use and abuse https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6376 Tue 14 May 2024 10:49:17 SAST ]]> A stability-indicating HPLC assay with on-line clean-up for betamethasone 17-valerate in topical dosage forms https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6421 Tue 14 May 2024 10:48:59 SAST ]]> High performance liquid chromatographic analysis of oleandomycin in serum and urine https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6429 Tue 14 May 2024 10:48:39 SAST ]]> A stability-indicating liquid chromatographic method for the analysis of erythromycin in stored biological fluids using amperometric detection https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6430 Tue 14 May 2024 10:48:10 SAST ]]> Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilizing the human skin-blanching assay https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6400 Tue 14 May 2024 10:47:47 SAST ]]> Comparison of the blanching activities of Dermovate, Betnovate and Eumovate creams and ointments https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6393 Tue 14 May 2024 10:47:18 SAST ]]> The human skin blanching assay for in vivo topical corticosteroid assessment. II. Subject- and observer-dependent variation in blanching responses https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6382 Tue 14 May 2024 10:45:44 SAST ]]> Evaluation of the proposed FDA pilot-dose response methodology for topical corticosteroid bioequivalence testing https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6356 0.95) was noted for both methods of assessment. The chromameter ED[subscript 50] values determined in this study were approximately 2 hours for both preparations. At this dose duration the instrument would not be sensitive enough to distinguish between weak blanching responses and normal skin for bioequivalence assessment purposes.]]> Tue 14 May 2024 10:45:10 SAST ]]> Evaluation of the proposed FDA pilot-dose response methodology for topical corticosteroid bioeqivalence testing [authors' reply in Letters to the Editor] https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6423 Tue 14 May 2024 10:44:40 SAST ]]> Phenylpropanolamine hydrochloride https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6385 Tue 14 May 2024 06:43:37 SAST ]]> Determination of phenylpropanolamine in serum and urine by high performance liquid chromatography https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6361 Tue 14 May 2024 06:43:09 SAST ]]> Pharmacokinetics of phenylpropanolamine in humans after a single dose study https://commons.ufh.ac.za/vital/access/manager/Repository/vital:6363 Tue 14 May 2024 06:42:30 SAST ]]>